Published in Front Mol Neurosci on October 15, 2014
Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector. Mol Ther (2015) 0.87
SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum Mol Genet (2015) 0.84
Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants. Mol Ther (2015) 0.84
Optical Tools to Investigate Cellular Activity in the Intestinal Wall. J Neurogastroenterol Motil (2015) 0.83
Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy. Histochem Cell Biol (2016) 0.80
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy. Mol Ther (2016) 0.77
Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci (2017) 0.76
Adeno-Associated Viral Vector Delivery to the Enteric Nervous System: A Review. Postdoc J (2015) 0.75
Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma (2004) 7.34
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet (2007) 7.01
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol (2008) 6.82
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol (2010) 4.62
The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol (2002) 3.59
Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther (2009) 3.33
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol (2006) 2.94
The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol (2012) 2.81
Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology (2007) 2.72
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther (2007) 2.64
Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics (2010) 2.45
Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther (2012) 2.42
Types of neurons in the enteric nervous system. J Auton Nerv Syst (2000) 2.28
Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol Ther (2011) 2.20
Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol (2007) 2.01
Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol Ther (2011) 1.96
Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp Neurol (2007) 1.89
Parkinson disease: the enteric nervous system spills its guts. Neurology (2011) 1.81
Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery. Mol Ther (2011) 1.79
Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. J Biol Chem (2011) 1.73
A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease. Mol Ther (2010) 1.68
Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Mol Ther (2009) 1.66
Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci U S A (2001) 1.63
The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J Clin Invest (2011) 1.58
Novel functional roles for enteric glia in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol (2012) 1.44
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. J Clin Invest (2013) 1.44
Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression. Mol Ther (2009) 1.42
Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol Ther (2013) 1.36
Neurochemical classification of enteric neurons in the guinea-pig distal colon. Cell Tissue Res (2000) 1.33
Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J Neurosci (2013) 1.26
Plasticity of the enteric nervous system during intestinal inflammation. Neurogastroenterol Motil (2005) 1.23
Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system. FASEB J (2011) 1.22
A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice. Mol Ther (2013) 1.19
Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol (2010) 1.14
Chronic intestinal pseudo-obstruction. Nutr Clin Pract (2013) 1.14
Anxiety, sensory over-responsivity, and gastrointestinal problems in children with autism spectrum disorders. J Abnorm Child Psychol (2013) 1.14
Epidemiology and burden of chronic constipation. Can J Gastroenterol (2011) 1.13
Ca2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice. Gastroenterology (2013) 1.12
Neuropathy in the brain-in-the-gut. Eur J Gastroenterol Hepatol (2000) 1.06
Enteric neurodegeneration in ageing. Neurogastroenterol Motil (2008) 1.06
Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems. Gene Ther (2012) 1.03
Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells. Gut (2013) 1.03
Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production. Neurogastroenterol Motil (2011) 1.00
Glial promoter selectivity following AAV-delivery to the immature brain. PLoS One (2013) 1.00
Properties of the enteric nervous system: limitation of access of intravascular macromolecules to the myenteric plexus and muscularis externa. J Comp Neurol (1978) 0.99
Cholinergic neurotransmission and muscarinic receptors in the enteric nervous system. Prog Histochem Cytochem (2009) 0.99
Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci (2001) 0.99
Impact of disrupting adenosine A₃ receptors (A₃⁻/⁻ AR) on colonic motility or progression of colitis in the mouse. Inflamm Bowel Dis (2010) 0.97
Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse. Front Neuroanat (2014) 0.96
Structural differences in the enteric neural network in murine colon: impact on electrophysiology. Am J Physiol Gastrointest Liver Physiol (2003) 0.95
The aging colon: the role of enteric neurodegeneration in constipation. Curr Gastroenterol Rep (2010) 0.94
Birthdating of myenteric neuron subtypes in the small intestine of the mouse. J Comp Neurol (2014) 0.93
Chemical coding of enteric neurons. Prog Brain Res (1986) 0.89
Morphologies and projections of defined classes of neurons in the submucosa of the guinea-pig small intestine. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.88
Parallel manifestations of neuropathologies in the enteric and central nervous systems. Neurogastroenterol Motil (2011) 0.86
Glial-neuronal interactions--implications for plasticity and drug addiction. AAPS J (2009) 0.83
Management and pathophysiology of functional gastrointestinal disorders. Digestion (2012) 0.82
Intravenous injections in neonatal mice. J Vis Exp (2014) 0.81
Targeted CNS Delivery Using Human MiniPromoters and Demonstrated Compatibility with Adeno-Associated Viral Vectors. Mol Ther Methods Clin Dev (2014) 0.81
Regional cholinergic differences between distal and proximal colonic myenteric plexus. Am J Physiol (1990) 0.81
Neuronal intranuclear inclusion disease presenting as chronic intestinal pseudo-obstruction in the neonatal period in the absence of neurologic symptoms. J Pediatr Gastroenterol Nutr (2006) 0.77
Primary gastrointestinal motility disorders in childhood. Minerva Pediatr (2012) 0.77